妊娠期游离甲状腺激素意外升高
一例35岁慢性自身免疫性甲状腺炎孕妇在孕26周时,临床甲状腺功能正常、TSH正常(0.79 mIU/L),但一步法化学发光检测显示游离三碘甲状腺原氨酸(fT3)和游离甲状腺素(fT4)升高,总甲状腺激素水平正常。产后fT4和fT3逐渐恢复正常,通过两步法检测及检出甲状腺激素自身抗体(THAb)证实为THAb干扰一步法检测所致。作者认为,当实验室数据与临床情况不一致时,应怀疑循环THAb,尽管其相对罕见。
要点
- 妊娠期出现游离甲状腺激素升高而TSH正常时,需考虑检测干扰。
- 循环甲状腺激素自身抗体(THAb)可干扰一步法甲状腺激素检测。
- 两步法检测及THAb测定有助于识别此类干扰。
核心结论
- 当实验室数据不一致且与临床情况矛盾时,尽管循环THAb相对罕见,仍应怀疑其存在。
- 据作者所知,此前未见妊娠期短暂出现THAb的病例报道。
研究设计与样本
- 病例报告:一例35岁已知慢性自身免疫性甲状腺炎的孕妇,在第二次妊娠第26周转诊至作者所在诊所,随访至整个妊娠期及产后12个月。
主要发现
- 患者临床甲状腺功能正常,血清TSH正常(0.79 mIU/L),但一步法化学发光检测显示fT3和fT4升高。
- 患者服用左甲状腺素替代治疗(125 μg/天),剂量已确认;既往血液检查显示TSH与游离甲状腺激素值一致。
- 妊娠期间,一步法检测的游离甲状腺激素持续升高,而总甲状腺激素浓度在参考范围内,与TSH值一致。
- 产后fT4和fT3值逐渐恢复正常,与TSH值一致。
- 使用储存的冷冻血清,通过两步法检测显示fT3和fT4水平正常,并直接证实存在针对两种激素的THAb,从而间接和直接证实了THAb假说。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of thyrotropin and free thyroid hormone assays to evaluate thyroid function is widespread, but in some situations the results are inconsistent with the patient's thyroid status. SUMMARY: A 35-year-old woman with a known diagnosis of chronic autoimmune thyroiditis was referred to the authors' clinic at week 26 of her second pregnancy. The patient was clinically euthyroid. Consistent with this, her serum thyrotropin (TSH) was normal (0.79 mIU/L), but she had elevated free thyroid hormones-free triiodothyronine (fT3) and free thyroxine (fT4)-as determined by a one-step chemiluminescent assay. The patient was taking levothyroxine replacement therapy (125 μg/day), and the dose was confirmed. Previous blood tests showed concordance between TSH and free thyroid hormone values. The patient was followed up throughout gestation and at 12 months postpartum. During gestation, her free thyroid hormones remained high using one-step methods, while the total thyroid hormone concentration values were within the reference range, in agreement with the TSH values. Postpartum fT4 and fT3 values returned progressively to normality, in agreement with the TSH values. The presence of circulating thyroid hormone autoantibodies (THAb) was hypothesized, which are known to interfere, although to a variable extent, with thyroid hormone one-step assays. Using stored frozen sera, this hypothesis was confirmed indirectly by measuring normal levels of fT3 and fT4 with a two-step method, and directly by demonstrating THAb against the two hormones. CONCLUSION: Despite their relative rarity, circulating THAb may be suspected when laboratory data are not consistent and contrast with the clinical picture. To the authors' knowledge, no previous case of transient appearance of THAb in pregnancy has been described.
引用
- Teti C, Nazzari E, Galletti MR, et al. Unexpected Elevated Free Thyroid Hormones in Pregnancy. Thyroid. 2016. PMID: 27538922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。